共 50 条
- [31] Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsMOLECULAR THERAPY, 2025, 33 (03) : 1014 - 1030Shankar, KeerthanaZingler-Hoslet, IsabelleTabima, Diana M.Zima, SethShi, LeiGimse, KirstanForsberg, Matthew H.Katta, VarunDavis, Sage Z.Maldonado, DanielRussell, Brittany E.Murtaza, MuhammedTsai, Shengdar Q.Ayuso, Jose M.Capitini, Christian M.Saha, Krishanu
- [32] NKG2D Chimeric Antigen receptor-expressing Lymphocytes Target Acute Myeloid Leukemia CellsBONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 260 - 261Leivas, AlejandraCordoba, LauraValeri, AntonioLiz Paciello, MariRio, PaulaPrimo, DanielBallesteros, JoanFernandez, LuciaPerez-Martinez, AntonioLee, Dean A.Powell, Daniel J., Jr.Martinez-Lopez, Joaquin
- [33] Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-GONCOIMMUNOLOGY, 2017, 6 (01):Kailayangiri, SareethaAltvater, BiancaSpurny, ChristianJamitzky, SilkeSchelhaas, SonjaJacobs, Andreas H.Wiek, ConstanzeRoellecke, KatharinaHanenberg, HelmutHartmann, WolfgangWiendl, HeinzPankratz, SusannMeltzer, JuttaFarwick, NicoleGreune, LeaFluegge, MaikeRossig, Claudia
- [34] Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotypeCYTOTHERAPY, 2019, 21 (06) : 593 - 602Gargett, TessaTruong, NgaEbert, Lisa M.Yu, WenboBrown, Michael P.
- [35] CARPETS: A Phase I study of the safety and immune effects of an escalating dose of autologous GD2 chimeric antigen receptor-expressing peripheral blood T cells in patients with GD2-positive metastatic melanoma and refractory solid tumorsCANCER RESEARCH, 2019, 79 (13)Brown, MichaelGargett, Tessa
- [36] Use of EBV-specific human T lymphocytes transduced with GD2-specific chimeric T cell receptor genes for tumor targeting.BLOOD, 2000, 96 (11) : 26A - 26ARossig, CNuchtern, JGMerchant, DABrenner, MK
- [37] Tumor-Associated Macrophages Via Up-Regulation of PD1 Ligands Protect Neuroblastoma from Immunotherapy With NKT Cells Expressing GD2-Specific Chimeric Antigen ReceptorMOLECULAR THERAPY, 2015, 23 : S205 - S205Liu, DaofengCourtney, Amy N.Heczey, AndrasMarinova, EkaterinaTian, GengwenGuo, LinjieGao, XiuhuaDotti, GianpietroMetelitsa, Leonid S.
- [38] Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells (vol 1, pg 100003, 2020)CELL REPORTS MEDICINE, 2020, 1 (05)Reighard, Seth D.Cranert, Stacey A.Rangel, Kelly M.Ali, AyadGyurova, Ivayla E.de la Cruz-Lynch, Arthur T.Tuazon, Jasmine A.Khodoun, Marat V.Kottyan, Leah C.Smith, David F.Brunner, Hermine I.Waggoner, Stephen N.
- [39] Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cellsBlood Cancer Journal, 12Nianci ChenYingxi XuJunli MouQing RaoHaiyan XingZheng TianKejing TangMin WangJianxiang Wang
- [40] Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem CellsBLOOD, 2013, 122 (21)Hermanson, David L.Ni, ZhenyaKnorr, David A.Bendzick, LauraPribyl, Lee J.Geller, MelissaKaufman, Dan S.